What deal terms XPLR XIFR XPLR posts 794 negative EPS surprise misses consensus estimates Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside Westlake WLKP Stock Sector Rotation Touches High 20260427